Anaplastic Lymphoma Kinase Mutation–Positive Non–Small Cell Lung Cancer
The treatment of patients with advanced non–small cell lung cancer with anaplastic lymphoma kinase chromosomal rearrangements has been revolutionized by the development of tyrosine kinase inhibitors (TKIs). Excellent progress has…